comparemela.com
Home
Live Updates
Stephen Tisch - Breaking News
Pages:
Latest Breaking News On - Stephen tisch - Page 1 : comparemela.com
Alterity Therapeutics Enrolls First Patient in Australia in
MELBOURNE, Australia and SAN FRANCISCO, May 10, 2023 (GLOBE NEWSWIRE) Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a.
New south wales
United states
San francisco
David stamler
Remy bernarda
Stephen tisch
Hannah howlett
Alterity therapeutics
Company phase
European commission
Multiple system atrophy
Chief executive officer
Principal investigator
System atrophy
Media contacts
Securities act
Alterity Therapeutics Enrolls First Patient in Australia in ATH434 Global Phase 2 Clinical Trial in Multiple System Atrophy
MELBOURNE, Australia and SAN FRANCISCO, May 10, 2023 Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today. | May 10, 2023
New south wales
United states
San francisco
David stamler
Hannah howlett
Stephen tisch
Remy bernarda
European commission
Company phase
Alterity therapeutics
Multiple system atrophy
Chief executive officer
Principal investigator
System atrophy
Media contacts
Alterity therapeutics limited stock exchange
vimarsana © 2020. All Rights Reserved.